查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1589796

马药品和补充品市场：按产品和分销管道 - 2025 年至 2030 年全球预测

Equine Pharmaceuticals & Supplements Market by Product (Pharmaceutical, Supplement), Distribution Channel (Drug Stores, Veterinary Hospitals) - Global Forecast 2025-2030
出版日期: | 出版商: 360iResearch | 英文 198 Pages | 商品交期: 最快1-2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

2023年，马匹药品和补充品市场价值为93052万美元，预计到2024年将达到98349万美元，复合年增长率为5.78%，到2030年将达到137952万美元。

马匹药品和补充品市场包括各种专用马匹配製的产品，包括旨在维持和促进马匹健康的药品、营养补充品和兽医治疗。这些产品的需求主要源自于马匹广泛参与需要最佳健康和表现的运动、农业和休閒活动。其用途范围从提供必需营养素、管理关节和骨骼健康到治疗特定的医疗状况。兽医、马治疗师、饲养员和马主是主要的最终用户，这凸显了这些产品对马业的重要性。市场成长受到诸如马健康意识增强、马疾病患病率上升以及对天然成分和配方的日益偏好等因素的强烈影响。此外，马术运动产业的扩张也为市场需求提供了重要动力。然而，市场面临原料成本波动、严格的监管环境以及需要进行全面研究来检验产品有效性等挑战。该领域的创新可以集中于开发先进的补充品输送系统、利用生物技术进步进行新颖的治疗，以及利用资料分析进行个人化的马匹健康管理。也可以研究和开发专门针对特定品种或病理状况的製剂。进入这一领域的公司应考虑建立策略伙伴关係和联盟，以加强分销并扩大产品线以瞄准利基市场。马术运动蓬勃发展的开拓领域存在潜在商机，企业需要製定有效的市场渗透和消费者教育策略。该市场是成熟公司和新兴企业公司的所在地，创造了一个需要持续技术创新和对品质承诺的竞争环境。儘管面临挑战，但在对专业和永续解决方案的持续需求的推动下，马药和补充品领域仍有望实现成长。

主要市场统计
基准年[2023] 93052万美元
预测年份 [2024] 98349万美元
预测年份 [2030] 1,379.52 百万美元
复合年增长率（%） 5.78%

市场动态：揭示快速发展的马药和补充品市场的关键市场洞察

马药品和补充品市场正在因供需的动态交互作用而转变。了解这些不断变化的市场动态可以帮助企业做出明智的投资决策、策略决策并抓住新的商机。全面了解这些趋势可以帮助企业降低政治、地理、技术、社会和经济领域的风险，并了解消费行为及其对製造成本的影响，并更清楚地了解对采购趋势的影响。

  • 市场驱动因素
    • 提高对马药品和补充品产品的认识
    • 由于养马者对有机产品的偏好，对草药饲料、消化助剂和能量补充品的需求增加
    • 在赛马和马术领域越来越多地采用马补充品
  • 市场限制因素
    • 关于药物和补充品的严格规定
  • 市场机会
    • 更关注马匹的整体健康和电解质补充品的广泛使用
    • 新马药和补充品的开发
  • 市场问题
    • 对马健康的副作用

波特的五力：驾驭马药和补充品市场的策略工具

波特的五力框架是了解市场竞争格局的重要工具。波特的五力框架描述了评估公司竞争和探索策略机会的清晰方法。该框架可帮助公司评估市场动态并确定新业务的盈利。这些见解使公司能够利用自己的优势，解决弱点，避免潜在的挑战，确保更强大的市场地位。

PESTLE分析：了解马药品和补充品市场的外部影响

外部宏观环境因素在影响马药和补充品市场的表现动态发挥着至关重要的作用。对政治、经济、社会、技术、法律和环境因素的分析提供了应对这些影响所需的资讯。透过调查 PESTLE 因素，公司可以更了解潜在的风险和机会。这种分析可以帮助公司预测法规、消费者偏好和经济趋势的变化，并帮助他们做出积极主动的决策。

市场占有率分析：了解马药品和补充品市场的竞争格局

马药品和补充品市场的详细市场占有率分析可以对供应商绩效进行全面评估。公司可以透过比较收益、客户群和成长率等关键指标来揭示自己的竞争定位。该分析揭示了市场集中、细分和整合的趋势，为供应商提供了製定策略决策所需的洞察力，使他们能够在日益激烈的竞争中占有一席之地。

FPNV 定位矩阵：马药品和补充品市场供应商的绩效评估

FPNV 定位矩阵是评估马药品和补充品市场供应商的重要工具。此矩阵允许业务组织根据商务策略和产品满意度评估供应商，从而做出与其目标相符的明智决策。这四个象限使您能够清晰、准确地划分供应商，并确定最能满足您的策略目标的合作伙伴和解决方案。

策略分析与建议：绘製马药和补充品市场的成功之路

对于希望加强在全球市场的影响力的公司来说，对马药品和补充品市场进行策略分析至关重要。透过审查关键资源、能力和绩效指标，公司可以识别成长机会并努力改进。这种方法使您能够克服竞争格局中的挑战，利用新的商机并取得长期成功。

该报告对涵盖关键焦点细分市场的市场进行了全面分析。

1. 市场渗透率：详细检视当前市场环境，主要企业的广泛资料，评估其在市场中的影响力和整体影响力。

2. 市场开拓：辨识新兴市场的成长机会，评估现有细分市场的扩张潜力，并提供未来成长的策略蓝图。

3. 市场多元化：分析近期产品发布、开拓地区、主要产业进展、塑造市场的策略投资。

4. 竞争评估与情报：彻底分析竞争格局，检验市场占有率、业务策略、产品系列、认证、监理核准、专利趋势、主要企业的技术进步等。

5. 产品开发与创新：重点在于有望推动未来市场成长的最尖端科技、研发活动和产品创新。

我们也回答重要问题，以帮助相关人员做出明智的决策。

1.目前的市场规模和未来的成长预测是多少？

2. 哪些产品和地区提供最佳投资机会？

3.塑造市场的关键技术趋势和监管影响是什么？

4.主要厂商的市场占有率和竞争地位如何？

5. 推动供应商市场进入和退出策略的收益来源和策略机会是什么？

目录

第一章 前言

第二章调查方法

第三章执行摘要

第四章市场概况

第五章市场洞察

  • 市场动态
    • 促进因素
      • 提高对马药品和补充品产品的认识
      • 有机产品越来越受到养马者的青睐，对草药饲料、消化助剂和能量补充品。
      • 赛马和马术领域更多地采用马补充品
    • 抑制因素
      • 关于药物和补充品的严格规定
    • 机会
      • 对马匹整体健康的日益重视导致电解质补充品的广泛使用
      • 新马药和补充品的开发
    • 任务
      • 对马健康的副作用
  • 市场区隔分析
  • 波特五力分析
  • PESTEL分析
    • 政治
    • 经济
    • 社会
    • 科技
    • 法律
    • 环境

第六章马药品和补充品市场：副产品

  • 介绍
  • 药品
    • 发炎（药
    • 抗溃疡药
    • 镇静剂和镇静剂
  • 补充品
    • 关节补充品
    • 维生素和矿物质

第七章马药品和补充品市场：按分销管道

  • 介绍
  • 药局
  • 动物医院

第八章北美和南美马药品和补充品市场

  • 介绍
  • 阿根廷
  • 巴西
  • 加拿大
  • 墨西哥
  • 美国

第九章亚太马药及补充品市场

  • 介绍
  • 澳洲
  • 中国
  • 印度
  • 印尼
  • 日本
  • 马来西亚
  • 菲律宾
  • 新加坡
  • 韩国
  • 台湾
  • 泰国
  • 越南

第十章 欧洲、中东和非洲的马药品和补充品市场

  • 介绍
  • 丹麦
  • 埃及
  • 芬兰
  • 法国
  • 德国
  • 以色列
  • 义大利
  • 荷兰
  • 奈及利亚
  • 挪威
  • 波兰
  • 卡达
  • 俄罗斯
  • 沙乌地阿拉伯
  • 南非
  • 西班牙
  • 瑞典
  • 瑞士
  • 土耳其
  • 阿拉伯聯合大公国
  • 英国

第十一章竞争格局

  • 2023 年市场占有率分析
  • FPNV 定位矩阵，2023
  • 竞争情境分析
  • 战略分析和建议

公司名单

  • Alltech
  • Bayer AG
  • Boehringer Ingelheim International GmbH
  • Cargill, Incorporated
  • Ceva Sante Animale
  • Dechra Veterinary Products Limited
  • Elanco Animal Health Incorporated
  • Equineproducts-uk Ltd.
  • Lallemand, Inc.
  • Merck & Co., Inc.
  • Purina Animal Nutrition LLC
  • Thermo Fisher Scientific Inc.
  • Vetoquinol USA
  • Virbac
  • Zoetis Inc.
Product Code: MRR-4348D129FACA

The Equine Pharmaceuticals & Supplements Market was valued at USD 930.52 million in 2023, expected to reach USD 983.49 million in 2024, and is projected to grow at a CAGR of 5.78%, to USD 1,379.52 million by 2030.

The equine pharmaceuticals and supplements market encompasses a diverse range of products that are formulated specifically for horses, including medications, nutritional supplements, and veterinary treatments aimed at maintaining and enhancing equine health. The necessity of these products emerges primarily from the extensive participation of equines in sports, agriculture, and leisure activities, which demands optimum health and performance. Applications range from providing essential nutrients and managing joint and bone health to treating specific medical conditions. Veterinarians, equine therapists, breeders, and horse owners represent the primary end-users, underlining the importance of these products in the equine industry. Market growth is strongly influenced by factors such as increasing awareness regarding horse health, the rising prevalence of equine diseases, and a growing inclination towards natural ingredients and formulations. Moreover, the expanding equestrian sports industry adds significant impetus to market demand. However, the market faces challenges such as fluctuating ingredient costs, stringent regulatory landscapes, and the need for comprehensive research to validate product efficacy. Innovations in this domain could focus on developing advanced delivery systems for supplements, leveraging biotechnological advancements for novel therapeutics, and utilizing data analytics for personalized equine health management. R&D efforts could also explore tailored formulations for specific breeds or conditions. Companies venturing into this space should consider strategic partnerships or collaborations for enhanced distribution and expanded product lines targeting niche markets. Potential opportunities exist within the untapped regions where equine sports are gaining traction, requiring companies to strategize market penetration and consumer education effectively. The market is characterized by both established firms and emerging players, fostering a competitive environment that necessitates consistent innovation and adherence to quality. Despite challenges, the equine pharmaceuticals and supplements sector is poised for growth, driven by continuous demand for specialized and sustainable solutions.

KEY MARKET STATISTICS
Base Year [2023] USD 930.52 million
Estimated Year [2024] USD 983.49 million
Forecast Year [2030] USD 1,379.52 million
CAGR (%) 5.78%

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Equine Pharmaceuticals & Supplements Market

The Equine Pharmaceuticals & Supplements Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

  • Market Drivers
    • Increasing awareness about equine pharmaceuticals and supplements products
    • Rising demand for herbal feed, digestive, and energy supplements owing to the choice among horse breeders for organic products
    • Growing adoption of equine supplements in horse racing and equestrian sectors
  • Market Restraints
    • Stringent regulations regarding the pharmaceutical products and supplements
  • Market Opportunities
    • Growing emphasis on overall equine health and wellness, and extensively use of electrolyte supplements
    • Development of new equine pharmaceuticals & supplements
  • Market Challenges
    • Side effects on the health of equine

Porter's Five Forces: A Strategic Tool for Navigating the Equine Pharmaceuticals & Supplements Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Equine Pharmaceuticals & Supplements Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Equine Pharmaceuticals & Supplements Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Equine Pharmaceuticals & Supplements Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Equine Pharmaceuticals & Supplements Market

A detailed market share analysis in the Equine Pharmaceuticals & Supplements Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Equine Pharmaceuticals & Supplements Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Equine Pharmaceuticals & Supplements Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the Equine Pharmaceuticals & Supplements Market

A strategic analysis of the Equine Pharmaceuticals & Supplements Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the Equine Pharmaceuticals & Supplements Market, highlighting leading vendors and their innovative profiles. These include Alltech, Bayer AG, Boehringer Ingelheim International GmbH, Cargill, Incorporated, Ceva Sante Animale, Dechra Veterinary Products Limited, Elanco Animal Health Incorporated, Equineproducts-uk Ltd., Lallemand, Inc., Merck & Co., Inc., Purina Animal Nutrition LLC, Thermo Fisher Scientific Inc., Vetoquinol USA, Virbac, and Zoetis Inc..

Market Segmentation & Coverage

This research report categorizes the Equine Pharmaceuticals & Supplements Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Based on Product, market is studied across Pharmaceutical and Supplement. The Pharmaceutical is further studied across Anti-Inflammatory, Anti-Ulcer Drugs, and Sedative & Tranquilizer. The Supplement is further studied across Joint Supplements and Vitamins & Minerals.
  • Based on Distribution Channel, market is studied across Drug Stores and Veterinary Hospitals.
  • Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Increasing awareness about equine pharmaceuticals and supplements products
      • 5.1.1.2. Rising demand for herbal feed, digestive, and energy supplements owing to the choice among horse breeders for organic products
      • 5.1.1.3. Growing adoption of equine supplements in horse racing and equestrian sectors
    • 5.1.2. Restraints
      • 5.1.2.1. Stringent regulations regarding the pharmaceutical products and supplements
    • 5.1.3. Opportunities
      • 5.1.3.1. Growing emphasis on overall equine health and wellness, and extensively use of electrolyte supplements
      • 5.1.3.2. Development of new equine pharmaceuticals & supplements
    • 5.1.4. Challenges
      • 5.1.4.1. Side effects on the health of equine
  • 5.2. Market Segmentation Analysis
  • 5.3. Porter's Five Forces Analysis
    • 5.3.1. Threat of New Entrants
    • 5.3.2. Threat of Substitutes
    • 5.3.3. Bargaining Power of Customers
    • 5.3.4. Bargaining Power of Suppliers
    • 5.3.5. Industry Rivalry
  • 5.4. PESTLE Analysis
    • 5.4.1. Political
    • 5.4.2. Economic
    • 5.4.3. Social
    • 5.4.4. Technological
    • 5.4.5. Legal
    • 5.4.6. Environmental

6. Equine Pharmaceuticals & Supplements Market, by Product

  • 6.1. Introduction
  • 6.2. Pharmaceutical
    • 6.2.1. Anti-Inflammatory
    • 6.2.2. Anti-Ulcer Drugs
    • 6.2.3. Sedative & Tranquilizer
  • 6.3. Supplement
    • 6.3.1. Joint Supplements
    • 6.3.2. Vitamins & Minerals

7. Equine Pharmaceuticals & Supplements Market, by Distribution Channel

  • 7.1. Introduction
  • 7.2. Drug Stores
  • 7.3. Veterinary Hospitals

8. Americas Equine Pharmaceuticals & Supplements Market

  • 8.1. Introduction
  • 8.2. Argentina
  • 8.3. Brazil
  • 8.4. Canada
  • 8.5. Mexico
  • 8.6. United States

9. Asia-Pacific Equine Pharmaceuticals & Supplements Market

  • 9.1. Introduction
  • 9.2. Australia
  • 9.3. China
  • 9.4. India
  • 9.5. Indonesia
  • 9.6. Japan
  • 9.7. Malaysia
  • 9.8. Philippines
  • 9.9. Singapore
  • 9.10. South Korea
  • 9.11. Taiwan
  • 9.12. Thailand
  • 9.13. Vietnam

10. Europe, Middle East & Africa Equine Pharmaceuticals & Supplements Market

  • 10.1. Introduction
  • 10.2. Denmark
  • 10.3. Egypt
  • 10.4. Finland
  • 10.5. France
  • 10.6. Germany
  • 10.7. Israel
  • 10.8. Italy
  • 10.9. Netherlands
  • 10.10. Nigeria
  • 10.11. Norway
  • 10.12. Poland
  • 10.13. Qatar
  • 10.14. Russia
  • 10.15. Saudi Arabia
  • 10.16. South Africa
  • 10.17. Spain
  • 10.18. Sweden
  • 10.19. Switzerland
  • 10.20. Turkey
  • 10.21. United Arab Emirates
  • 10.22. United Kingdom

11. Competitive Landscape

  • 11.1. Market Share Analysis, 2023
  • 11.2. FPNV Positioning Matrix, 2023
  • 11.3. Competitive Scenario Analysis
  • 11.4. Strategy Analysis & Recommendation

Companies Mentioned

  • 1. Alltech
  • 2. Bayer AG
  • 3. Boehringer Ingelheim International GmbH
  • 4. Cargill, Incorporated
  • 5. Ceva Sante Animale
  • 6. Dechra Veterinary Products Limited
  • 7. Elanco Animal Health Incorporated
  • 8. Equineproducts-uk Ltd.
  • 9. Lallemand, Inc.
  • 10. Merck & Co., Inc.
  • 11. Purina Animal Nutrition LLC
  • 12. Thermo Fisher Scientific Inc.
  • 13. Vetoquinol USA
  • 14. Virbac
  • 15. Zoetis Inc.

LIST OF FIGURES

  • FIGURE 1. EQUINE PHARMACEUTICALS & SUPPLEMENTS MARKET RESEARCH PROCESS
  • FIGURE 2. EQUINE PHARMACEUTICALS & SUPPLEMENTS MARKET SIZE, 2023 VS 2030
  • FIGURE 3. GLOBAL EQUINE PHARMACEUTICALS & SUPPLEMENTS MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 4. GLOBAL EQUINE PHARMACEUTICALS & SUPPLEMENTS MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 5. GLOBAL EQUINE PHARMACEUTICALS & SUPPLEMENTS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 6. GLOBAL EQUINE PHARMACEUTICALS & SUPPLEMENTS MARKET SIZE, BY PRODUCT, 2023 VS 2030 (%)
  • FIGURE 7. GLOBAL EQUINE PHARMACEUTICALS & SUPPLEMENTS MARKET SIZE, BY PRODUCT, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 8. GLOBAL EQUINE PHARMACEUTICALS & SUPPLEMENTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2023 VS 2030 (%)
  • FIGURE 9. GLOBAL EQUINE PHARMACEUTICALS & SUPPLEMENTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 10. AMERICAS EQUINE PHARMACEUTICALS & SUPPLEMENTS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 11. AMERICAS EQUINE PHARMACEUTICALS & SUPPLEMENTS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 12. UNITED STATES EQUINE PHARMACEUTICALS & SUPPLEMENTS MARKET SIZE, BY STATE, 2023 VS 2030 (%)
  • FIGURE 13. UNITED STATES EQUINE PHARMACEUTICALS & SUPPLEMENTS MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 14. ASIA-PACIFIC EQUINE PHARMACEUTICALS & SUPPLEMENTS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 15. ASIA-PACIFIC EQUINE PHARMACEUTICALS & SUPPLEMENTS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 16. EUROPE, MIDDLE EAST & AFRICA EQUINE PHARMACEUTICALS & SUPPLEMENTS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 17. EUROPE, MIDDLE EAST & AFRICA EQUINE PHARMACEUTICALS & SUPPLEMENTS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 18. EQUINE PHARMACEUTICALS & SUPPLEMENTS MARKET SHARE, BY KEY PLAYER, 2023
  • FIGURE 19. EQUINE PHARMACEUTICALS & SUPPLEMENTS MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

  • TABLE 1. EQUINE PHARMACEUTICALS & SUPPLEMENTS MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
  • TABLE 3. GLOBAL EQUINE PHARMACEUTICALS & SUPPLEMENTS MARKET SIZE, 2018-2030 (USD MILLION)
  • TABLE 4. GLOBAL EQUINE PHARMACEUTICALS & SUPPLEMENTS MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 5. GLOBAL EQUINE PHARMACEUTICALS & SUPPLEMENTS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 6. EQUINE PHARMACEUTICALS & SUPPLEMENTS MARKET DYNAMICS
  • TABLE 7. GLOBAL EQUINE PHARMACEUTICALS & SUPPLEMENTS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 8. GLOBAL EQUINE PHARMACEUTICALS & SUPPLEMENTS MARKET SIZE, BY PHARMACEUTICAL, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 9. GLOBAL EQUINE PHARMACEUTICALS & SUPPLEMENTS MARKET SIZE, BY ANTI-INFLAMMATORY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 10. GLOBAL EQUINE PHARMACEUTICALS & SUPPLEMENTS MARKET SIZE, BY ANTI-ULCER DRUGS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 11. GLOBAL EQUINE PHARMACEUTICALS & SUPPLEMENTS MARKET SIZE, BY SEDATIVE & TRANQUILIZER, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 12. GLOBAL EQUINE PHARMACEUTICALS & SUPPLEMENTS MARKET SIZE, BY PHARMACEUTICAL, 2018-2030 (USD MILLION)
  • TABLE 13. GLOBAL EQUINE PHARMACEUTICALS & SUPPLEMENTS MARKET SIZE, BY SUPPLEMENT, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 14. GLOBAL EQUINE PHARMACEUTICALS & SUPPLEMENTS MARKET SIZE, BY JOINT SUPPLEMENTS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 15. GLOBAL EQUINE PHARMACEUTICALS & SUPPLEMENTS MARKET SIZE, BY VITAMINS & MINERALS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 16. GLOBAL EQUINE PHARMACEUTICALS & SUPPLEMENTS MARKET SIZE, BY SUPPLEMENT, 2018-2030 (USD MILLION)
  • TABLE 17. GLOBAL EQUINE PHARMACEUTICALS & SUPPLEMENTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 18. GLOBAL EQUINE PHARMACEUTICALS & SUPPLEMENTS MARKET SIZE, BY DRUG STORES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 19. GLOBAL EQUINE PHARMACEUTICALS & SUPPLEMENTS MARKET SIZE, BY VETERINARY HOSPITALS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 20. AMERICAS EQUINE PHARMACEUTICALS & SUPPLEMENTS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 21. AMERICAS EQUINE PHARMACEUTICALS & SUPPLEMENTS MARKET SIZE, BY PHARMACEUTICAL, 2018-2030 (USD MILLION)
  • TABLE 22. AMERICAS EQUINE PHARMACEUTICALS & SUPPLEMENTS MARKET SIZE, BY SUPPLEMENT, 2018-2030 (USD MILLION)
  • TABLE 23. AMERICAS EQUINE PHARMACEUTICALS & SUPPLEMENTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 24. AMERICAS EQUINE PHARMACEUTICALS & SUPPLEMENTS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 25. ARGENTINA EQUINE PHARMACEUTICALS & SUPPLEMENTS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 26. ARGENTINA EQUINE PHARMACEUTICALS & SUPPLEMENTS MARKET SIZE, BY PHARMACEUTICAL, 2018-2030 (USD MILLION)
  • TABLE 27. ARGENTINA EQUINE PHARMACEUTICALS & SUPPLEMENTS MARKET SIZE, BY SUPPLEMENT, 2018-2030 (USD MILLION)
  • TABLE 28. ARGENTINA EQUINE PHARMACEUTICALS & SUPPLEMENTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 29. BRAZIL EQUINE PHARMACEUTICALS & SUPPLEMENTS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 30. BRAZIL EQUINE PHARMACEUTICALS & SUPPLEMENTS MARKET SIZE, BY PHARMACEUTICAL, 2018-2030 (USD MILLION)
  • TABLE 31. BRAZIL EQUINE PHARMACEUTICALS & SUPPLEMENTS MARKET SIZE, BY SUPPLEMENT, 2018-2030 (USD MILLION)
  • TABLE 32. BRAZIL EQUINE PHARMACEUTICALS & SUPPLEMENTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 33. CANADA EQUINE PHARMACEUTICALS & SUPPLEMENTS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 34. CANADA EQUINE PHARMACEUTICALS & SUPPLEMENTS MARKET SIZE, BY PHARMACEUTICAL, 2018-2030 (USD MILLION)
  • TABLE 35. CANADA EQUINE PHARMACEUTICALS & SUPPLEMENTS MARKET SIZE, BY SUPPLEMENT, 2018-2030 (USD MILLION)
  • TABLE 36. CANADA EQUINE PHARMACEUTICALS & SUPPLEMENTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 37. MEXICO EQUINE PHARMACEUTICALS & SUPPLEMENTS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 38. MEXICO EQUINE PHARMACEUTICALS & SUPPLEMENTS MARKET SIZE, BY PHARMACEUTICAL, 2018-2030 (USD MILLION)
  • TABLE 39. MEXICO EQUINE PHARMACEUTICALS & SUPPLEMENTS MARKET SIZE, BY SUPPLEMENT, 2018-2030 (USD MILLION)
  • TABLE 40. MEXICO EQUINE PHARMACEUTICALS & SUPPLEMENTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 41. UNITED STATES EQUINE PHARMACEUTICALS & SUPPLEMENTS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 42. UNITED STATES EQUINE PHARMACEUTICALS & SUPPLEMENTS MARKET SIZE, BY PHARMACEUTICAL, 2018-2030 (USD MILLION)
  • TABLE 43. UNITED STATES EQUINE PHARMACEUTICALS & SUPPLEMENTS MARKET SIZE, BY SUPPLEMENT, 2018-2030 (USD MILLION)
  • TABLE 44. UNITED STATES EQUINE PHARMACEUTICALS & SUPPLEMENTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 45. UNITED STATES EQUINE PHARMACEUTICALS & SUPPLEMENTS MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
  • TABLE 46. ASIA-PACIFIC EQUINE PHARMACEUTICALS & SUPPLEMENTS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 47. ASIA-PACIFIC EQUINE PHARMACEUTICALS & SUPPLEMENTS MARKET SIZE, BY PHARMACEUTICAL, 2018-2030 (USD MILLION)
  • TABLE 48. ASIA-PACIFIC EQUINE PHARMACEUTICALS & SUPPLEMENTS MARKET SIZE, BY SUPPLEMENT, 2018-2030 (USD MILLION)
  • TABLE 49. ASIA-PACIFIC EQUINE PHARMACEUTICALS & SUPPLEMENTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 50. ASIA-PACIFIC EQUINE PHARMACEUTICALS & SUPPLEMENTS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 51. AUSTRALIA EQUINE PHARMACEUTICALS & SUPPLEMENTS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 52. AUSTRALIA EQUINE PHARMACEUTICALS & SUPPLEMENTS MARKET SIZE, BY PHARMACEUTICAL, 2018-2030 (USD MILLION)
  • TABLE 53. AUSTRALIA EQUINE PHARMACEUTICALS & SUPPLEMENTS MARKET SIZE, BY SUPPLEMENT, 2018-2030 (USD MILLION)
  • TABLE 54. AUSTRALIA EQUINE PHARMACEUTICALS & SUPPLEMENTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 55. CHINA EQUINE PHARMACEUTICALS & SUPPLEMENTS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 56. CHINA EQUINE PHARMACEUTICALS & SUPPLEMENTS MARKET SIZE, BY PHARMACEUTICAL, 2018-2030 (USD MILLION)
  • TABLE 57. CHINA EQUINE PHARMACEUTICALS & SUPPLEMENTS MARKET SIZE, BY SUPPLEMENT, 2018-2030 (USD MILLION)
  • TABLE 58. CHINA EQUINE PHARMACEUTICALS & SUPPLEMENTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 59. INDIA EQUINE PHARMACEUTICALS & SUPPLEMENTS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 60. INDIA EQUINE PHARMACEUTICALS & SUPPLEMENTS MARKET SIZE, BY PHARMACEUTICAL, 2018-2030 (USD MILLION)
  • TABLE 61. INDIA EQUINE PHARMACEUTICALS & SUPPLEMENTS MARKET SIZE, BY SUPPLEMENT, 2018-2030 (USD MILLION)
  • TABLE 62. INDIA EQUINE PHARMACEUTICALS & SUPPLEMENTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 63. INDONESIA EQUINE PHARMACEUTICALS & SUPPLEMENTS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 64. INDONESIA EQUINE PHARMACEUTICALS & SUPPLEMENTS MARKET SIZE, BY PHARMACEUTICAL, 2018-2030 (USD MILLION)
  • TABLE 65. INDONESIA EQUINE PHARMACEUTICALS & SUPPLEMENTS MARKET SIZE, BY SUPPLEMENT, 2018-2030 (USD MILLION)
  • TABLE 66. INDONESIA EQUINE PHARMACEUTICALS & SUPPLEMENTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 67. JAPAN EQUINE PHARMACEUTICALS & SUPPLEMENTS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 68. JAPAN EQUINE PHARMACEUTICALS & SUPPLEMENTS MARKET SIZE, BY PHARMACEUTICAL, 2018-2030 (USD MILLION)
  • TABLE 69. JAPAN EQUINE PHARMACEUTICALS & SUPPLEMENTS MARKET SIZE, BY SUPPLEMENT, 2018-2030 (USD MILLION)
  • TABLE 70. JAPAN EQUINE PHARMACEUTICALS & SUPPLEMENTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 71. MALAYSIA EQUINE PHARMACEUTICALS & SUPPLEMENTS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 72. MALAYSIA EQUINE PHARMACEUTICALS & SUPPLEMENTS MARKET SIZE, BY PHARMACEUTICAL, 2018-2030 (USD MILLION)
  • TABLE 73. MALAYSIA EQUINE PHARMACEUTICALS & SUPPLEMENTS MARKET SIZE, BY SUPPLEMENT, 2018-2030 (USD MILLION)
  • TABLE 74. MALAYSIA EQUINE PHARMACEUTICALS & SUPPLEMENTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 75. PHILIPPINES EQUINE PHARMACEUTICALS & SUPPLEMENTS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 76. PHILIPPINES EQUINE PHARMACEUTICALS & SUPPLEMENTS MARKET SIZE, BY PHARMACEUTICAL, 2018-2030 (USD MILLION)
  • TABLE 77. PHILIPPINES EQUINE PHARMACEUTICALS & SUPPLEMENTS MARKET SIZE, BY SUPPLEMENT, 2018-2030 (USD MILLION)
  • TABLE 78. PHILIPPINES EQUINE PHARMACEUTICALS & SUPPLEMENTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 79. SINGAPORE EQUINE PHARMACEUTICALS & SUPPLEMENTS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 80. SINGAPORE EQUINE PHARMACEUTICALS & SUPPLEMENTS MARKET SIZE, BY PHARMACEUTICAL, 2018-2030 (USD MILLION)
  • TABLE 81. SINGAPORE EQUINE PHARMACEUTICALS & SUPPLEMENTS MARKET SIZE, BY SUPPLEMENT, 2018-2030 (USD MILLION)
  • TABLE 82. SINGAPORE EQUINE PHARMACEUTICALS & SUPPLEMENTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 83. SOUTH KOREA EQUINE PHARMACEUTICALS & SUPPLEMENTS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 84. SOUTH KOREA EQUINE PHARMACEUTICALS & SUPPLEMENTS MARKET SIZE, BY PHARMACEUTICAL, 2018-2030 (USD MILLION)
  • TABLE 85. SOUTH KOREA EQUINE PHARMACEUTICALS & SUPPLEMENTS MARKET SIZE, BY SUPPLEMENT, 2018-2030 (USD MILLION)
  • TABLE 86. SOUTH KOREA EQUINE PHARMACEUTICALS & SUPPLEMENTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 87. TAIWAN EQUINE PHARMACEUTICALS & SUPPLEMENTS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 88. TAIWAN EQUINE PHARMACEUTICALS & SUPPLEMENTS MARKET SIZE, BY PHARMACEUTICAL, 2018-2030 (USD MILLION)
  • TABLE 89. TAIWAN EQUINE PHARMACEUTICALS & SUPPLEMENTS MARKET SIZE, BY SUPPLEMENT, 2018-2030 (USD MILLION)
  • TABLE 90. TAIWAN EQUINE PHARMACEUTICALS & SUPPLEMENTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 91. THAILAND EQUINE PHARMACEUTICALS & SUPPLEMENTS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 92. THAILAND EQUINE PHARMACEUTICALS & SUPPLEMENTS MARKET SIZE, BY PHARMACEUTICAL, 2018-2030 (USD MILLION)
  • TABLE 93. THAILAND EQUINE PHARMACEUTICALS & SUPPLEMENTS MARKET SIZE, BY SUPPLEMENT, 2018-2030 (USD MILLION)
  • TABLE 94. THAILAND EQUINE PHARMACEUTICALS & SUPPLEMENTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 95. VIETNAM EQUINE PHARMACEUTICALS & SUPPLEMENTS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 96. VIETNAM EQUINE PHARMACEUTICALS & SUPPLEMENTS MARKET SIZE, BY PHARMACEUTICAL, 2018-2030 (USD MILLION)
  • TABLE 97. VIETNAM EQUINE PHARMACEUTICALS & SUPPLEMENTS MARKET SIZE, BY SUPPLEMENT, 2018-2030 (USD MILLION)
  • TABLE 98. VIETNAM EQUINE PHARMACEUTICALS & SUPPLEMENTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 99. EUROPE, MIDDLE EAST & AFRICA EQUINE PHARMACEUTICALS & SUPPLEMENTS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 100. EUROPE, MIDDLE EAST & AFRICA EQUINE PHARMACEUTICALS & SUPPLEMENTS MARKET SIZE, BY PHARMACEUTICAL, 2018-2030 (USD MILLION)
  • TABLE 101. EUROPE, MIDDLE EAST & AFRICA EQUINE PHARMACEUTICALS & SUPPLEMENTS MARKET SIZE, BY SUPPLEMENT, 2018-2030 (USD MILLION)
  • TABLE 102. EUROPE, MIDDLE EAST & AFRICA EQUINE PHARMACEUTICALS & SUPPLEMENTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 103. EUROPE, MIDDLE EAST & AFRICA EQUINE PHARMACEUTICALS & SUPPLEMENTS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 104. DENMARK EQUINE PHARMACEUTICALS & SUPPLEMENTS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 105. DENMARK EQUINE PHARMACEUTICALS & SUPPLEMENTS MARKET SIZE, BY PHARMACEUTICAL, 2018-2030 (USD MILLION)
  • TABLE 106. DENMARK EQUINE PHARMACEUTICALS & SUPPLEMENTS MARKET SIZE, BY SUPPLEMENT, 2018-2030 (USD MILLION)
  • TABLE 107. DENMARK EQUINE PHARMACEUTICALS & SUPPLEMENTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 108. EGYPT EQUINE PHARMACEUTICALS & SUPPLEMENTS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 109. EGYPT EQUINE PHARMACEUTICALS & SUPPLEMENTS MARKET SIZE, BY PHARMACEUTICAL, 2018-2030 (USD MILLION)
  • TABLE 110. EGYPT EQUINE PHARMACEUTICALS & SUPPLEMENTS MARKET SIZE, BY SUPPLEMENT, 2018-2030 (USD MILLION)
  • TABLE 111. EGYPT EQUINE PHARMACEUTICALS & SUPPLEMENTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 112. FINLAND EQUINE PHARMACEUTICALS & SUPPLEMENTS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 113. FINLAND EQUINE PHARMACEUTICALS & SUPPLEMENTS MARKET SIZE, BY PHARMACEUTICAL, 2018-2030 (USD MILLION)
  • TABLE 114. FINLAND EQUINE PHARMACEUTICALS & SUPPLEMENTS MARKET SIZE, BY SUPPLEMENT, 2018-2030 (USD MILLION)
  • TABLE 115. FINLAND EQUINE PHARMACEUTICALS & SUPPLEMENTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 116. FRANCE EQUINE PHARMACEUTICALS & SUPPLEMENTS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 117. FRANCE EQUINE PHARMACEUTICALS & SUPPLEMENTS MARKET SIZE, BY PHARMACEUTICAL, 2018-2030 (USD MILLION)
  • TABLE 118. FRANCE EQUINE PHARMACEUTICALS & SUPPLEMENTS MARKET SIZE, BY SUPPLEMENT, 2018-2030 (USD MILLION)
  • TABLE 119. FRANCE EQUINE PHARMACEUTICALS & SUPPLEMENTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 120. GERMANY EQUINE PHARMACEUTICALS & SUPPLEMENTS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 121. GERMANY EQUINE PHARMACEUTICALS & SUPPLEMENTS MARKET SIZE, BY PHARMACEUTICAL, 2018-2030 (USD MILLION)
  • TABLE 122. GERMANY EQUINE PHARMACEUTICALS & SUPPLEMENTS MARKET SIZE, BY SUPPLEMENT, 2018-2030 (USD MILLION)
  • TABLE 123. GERMANY EQUINE PHARMACEUTICALS & SUPPLEMENTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 124. ISRAEL EQUINE PHARMACEUTICALS & SUPPLEMENTS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 125. ISRAEL EQUINE PHARMACEUTICALS & SUPPLEMENTS MARKET SIZE, BY PHARMACEUTICAL, 2018-2030 (USD MILLION)
  • TABLE 126. ISRAEL EQUINE PHARMACEUTICALS & SUPPLEMENTS MARKET SIZE, BY SUPPLEMENT, 2018-2030 (USD MILLION)
  • TABLE 127. ISRAEL EQUINE PHARMACEUTICALS & SUPPLEMENTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 128. ITALY EQUINE PHARMACEUTICALS & SUPPLEMENTS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 129. ITALY EQUINE PHARMACEUTICALS & SUPPLEMENTS MARKET SIZE, BY PHARMACEUTICAL, 2018-2030 (USD MILLION)
  • TABLE 130. ITALY EQUINE PHARMACEUTICALS & SUPPLEMENTS MARKET SIZE, BY SUPPLEMENT, 2018-2030 (USD MILLION)
  • TABLE 131. ITALY EQUINE PHARMACEUTICALS & SUPPLEMENTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 132. NETHERLANDS EQUINE PHARMACEUTICALS & SUPPLEMENTS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 133. NETHERLANDS EQUINE PHARMACEUTICALS & SUPPLEMENTS MARKET SIZE, BY PHARMACEUTICAL, 2018-2030 (USD MILLION)
  • TABLE 134. NETHERLANDS EQUINE PHARMACEUTICALS & SUPPLEMENTS MARKET SIZE, BY SUPPLEMENT, 2018-2030 (USD MILLION)
  • TABLE 135. NETHERLANDS EQUINE PHARMACEUTICALS & SUPPLEMENTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 136. NIGERIA EQUINE PHARMACEUTICALS & SUPPLEMENTS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 137. NIGERIA EQUINE PHARMACEUTICALS & SUPPLEMENTS MARKET SIZE, BY PHARMACEUTICAL, 2018-2030 (USD MILLION)
  • TABLE 138. NIGERIA EQUINE PHARMACEUTICALS & SUPPLEMENTS MARKET SIZE, BY SUPPLEMENT, 2018-2030 (USD MILLION)
  • TABLE 139. NIGERIA EQUINE PHARMACEUTICALS & SUPPLEMENTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 140. NORWAY EQUINE PHARMACEUTICALS & SUPPLEMENTS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 141. NORWAY EQUINE PHARMACEUTICALS & SUPPLEMENTS MARKET SIZE, BY PHARMACEUTICAL, 2018-2030 (USD MILLION)
  • TABLE 142. NORWAY EQUINE PHARMACEUTICALS & SUPPLEMENTS MARKET SIZE, BY SUPPLEMENT, 2018-2030 (USD MILLION)
  • TABLE 143. NORWAY EQUINE PHARMACEUTICALS & SUPPLEMENTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 144. POLAND EQUINE PHARMACEUTICALS & SUPPLEMENTS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 145. POLAND EQUINE PHARMACEUTICALS & SUPPLEMENTS MARKET SIZE, BY PHARMACEUTICAL, 2018-2030 (USD MILLION)
  • TABLE 146. POLAND EQUINE PHARMACEUTICALS & SUPPLEMENTS MARKET SIZE, BY SUPPLEMENT, 2018-2030 (USD MILLION)
  • TABLE 147. POLAND EQUINE PHARMACEUTICALS & SUPPLEMENTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 148. QATAR EQUINE PHARMACEUTICALS & SUPPLEMENTS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 149. QATAR EQUINE PHARMACEUTICALS & SUPPLEMENTS MARKET SIZE, BY PHARMACEUTICAL, 2018-2030 (USD MILLION)
  • TABLE 150. QATAR EQUINE PHARMACEUTICALS & SUPPLEMENTS MARKET SIZE, BY SUPPLEMENT, 2018-2030 (USD MILLION)
  • TABLE 151. QATAR EQUINE PHARMACEUTICALS & SUPPLEMENTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 152. RUSSIA EQUINE PHARMACEUTICALS & SUPPLEMENTS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 153. RUSSIA EQUINE PHARMACEUTICALS & SUPPLEMENTS MARKET SIZE, BY PHARMACEUTICAL, 2018-2030 (USD MILLION)
  • TABLE 154. RUSSIA EQUINE PHARMACEUTICALS & SUPPLEMENTS MARKET SIZE, BY SUPPLEMENT, 2018-2030 (USD MILLION)
  • TABLE 155. RUSSIA EQUINE PHARMACEUTICALS & SUPPLEMENTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 156. SAUDI ARABIA EQUINE PHARMACEUTICALS & SUPPLEMENTS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 157. SAUDI ARABIA EQUINE PHARMACEUTICALS & SUPPLEMENTS MARKET SIZE, BY PHARMACEUTICAL, 2018-2030 (USD MILLION)
  • TABLE 158. SAUDI ARABIA EQUINE PHARMACEUTICALS & SUPPLEMENTS MARKET SIZE, BY SUPPLEMENT, 2018-2030 (USD MILLION)
  • TABLE 159. SAUDI ARABIA EQUINE PHARMACEUTICALS & SUPPLEMENTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 160. SOUTH AFRICA EQUINE PHARMACEUTICALS & SUPPLEMENTS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 161. SOUTH AFRICA EQUINE PHARMACEUTICALS & SUPPLEMENTS MARKET SIZE, BY PHARMACEUTICAL, 2018-2030 (USD MILLION)
  • TABLE 162. SOUTH AFRICA EQUINE PHARMACEUTICALS & SUPPLEMENTS MARKET SIZE, BY SUPPLEMENT, 2018-2030 (USD MILLION)
  • TABLE 163. SOUTH AFRICA EQUINE PHARMACEUTICALS & SUPPLEMENTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 164. SPAIN EQUINE PHARMACEUTICALS & SUPPLEMENTS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 165. SPAIN EQUINE PHARMACEUTICALS & SUPPLEMENTS MARKET SIZE, BY PHARMACEUTICAL, 2018-2030 (USD MILLION)
  • TABLE 166. SPAIN EQUINE PHARMACEUTICALS & SUPPLEMENTS MARKET SIZE, BY SUPPLEMENT, 2018-2030 (USD MILLION)
  • TABLE 167. SPAIN EQUINE PHARMACEUTICALS & SUPPLEMENTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 168. SWEDEN EQUINE PHARMACEUTICALS & SUPPLEMENTS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 169. SWEDEN EQUINE PHARMACEUTICALS & SUPPLEMENTS MARKET SIZE, BY PHARMACEUTICAL, 2018-2030 (USD MILLION)
  • TABLE 170. SWEDEN EQUINE PHARMACEUTICALS & SUPPLEMENTS MARKET SIZE, BY SUPPLEMENT, 2018-2030 (USD MILLION)
  • TABLE 171. SWEDEN EQUINE PHARMACEUTICALS & SUPPLEMENTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 172. SWITZERLAND EQUINE PHARMACEUTICALS & SUPPLEMENTS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 173. SWITZERLAND EQUINE PHARMACEUTICALS & SUPPLEMENTS MARKET SIZE, BY PHARMACEUTICAL, 2018-2030 (USD MILLION)
  • TABLE 174. SWITZERLAND EQUINE PHARMACEUTICALS & SUPPLEMENTS MARKET SIZE, BY SUPPLEMENT, 2018-2030 (USD MILLION)
  • TABLE 175. SWITZERLAND EQUINE PHARMACEUTICALS & SUPPLEMENTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 176. TURKEY EQUINE PHARMACEUTICALS & SUPPLEMENTS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 177. TURKEY EQUINE PHARMACEUTICALS & SUPPLEMENTS MARKET SIZE, BY PHARMACEUTICAL, 2018-2030 (USD MILLION)
  • TABLE 178. TURKEY EQUINE PHARMACEUTICALS & SUPPLEMENTS MARKET SIZE, BY SUPPLEMENT, 2018-2030 (USD MILLION)
  • TABLE 179. TURKEY EQUINE PHARMACEUTICALS & SUPPLEMENTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 180. UNITED ARAB EMIRATES EQUINE PHARMACEUTICALS & SUPPLEMENTS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 181. UNITED ARAB EMIRATES EQUINE PHARMACEUTICALS & SUPPLEMENTS MARKET SIZE, BY PHARMACEUTICAL, 2018-2030 (USD MILLION)
  • TABLE 182. UNITED ARAB EMIRATES EQUINE PHARMACEUTICALS & SUPPLEMENTS MARKET SIZE, BY SUPPLEMENT, 2018-2030 (USD MILLION)
  • TABLE 183. UNITED ARAB EMIRATES EQUINE PHARMACEUTICALS & SUPPLEMENTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 184. UNITED KINGDOM EQUINE PHARMACEUTICALS & SUPPLEMENTS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 185. UNITED KINGDOM EQUINE PHARMACEUTICALS & SUPPLEMENTS MARKET SIZE, BY PHARMACEUTICAL, 2018-2030 (USD MILLION)
  • TABLE 186. UNITED KINGDOM EQUINE PHARMACEUTICALS & SUPPLEMENTS MARKET SIZE, BY SUPPLEMENT, 2018-2030 (USD MILLION)
  • TABLE 187. UNITED KINGDOM EQUINE PHARMACEUTICALS & SUPPLEMENTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 188. EQUINE PHARMACEUTICALS & SUPPLEMENTS MARKET SHARE, BY KEY PLAYER, 2023
  • TABLE 189. EQUINE PHARMACEUTICALS & SUPPLEMENTS MARKET, FPNV POSITIONING MATRIX, 2023